Lixte Biotechnology
(NASDAQ) LIXT
Lixte Biotechnology Financials at a Glance
Market Cap
$24.44M
Revenue (TTM)
$0.00
Net Income (TTM)
$6.08B
EPS (TTM)
$-1.23
P/E Ratio
-2.48
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$3.12
Volume
549
Open
$3.00
Price
$3.12
Volume
549
Open
$3.00
Previous Close
$3.12
Daily Range
$2.97 - $3.12
52-Week Range
$0.64 - $6.26
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$3.12
Volume
549
Open
$3.00
Previous Close
$3.12
Daily Range
$2.97 - $3.12
52-Week Range
$0.64 - $6.26
LIXT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lixte Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
Geordan G. Pursglove
Website
www.lixte.comHeadquarters
Pasadena, CA 91101, US
LIXT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-115%
Return on Capital
-45%
Return on Assets
-48%
Earnings Yield
-40.32%
Dividend Yield
0.00%
Payout Ratio
-1.14%
Stock Overview
Market Cap
$24.44M
Shares Outstanding
8.01M
Volume
549
Short Interest
0.00%
Avg. Volume
66.26K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$5.11B
EBITDA
$5.11B
Operating Cash Flow
$3.07B
Capital Expenditure
$0.00
Free Cash Flow
$3.07B
Cash & ST Invst.
$5.11B
Total Debt
$1.03B
Lixte Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$24.44M
N/A
Market Cap/Employee
$12.22M
N/A
Employees
2
N/A
Net Income
$6.08B
-983409.1%
EBITDA
$5.10B
N/A
Quarterly Fundamentals
Net Cash
$4.07B
+391881.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$438.96M
N/A
Short Term Debt
$595.42M
N/A
Return on Assets
-47.74%
N/A
Return on Invested Capital
-44.80%
N/A
Free Cash Flow
$3.07B
-512471.1%
Operating Cash Flow
$3.07B
-512471.1%